Agenda
This program has been accredited by EBAC for 1 hour of CME credit.
-
15:00 GMT
Welcome and introductions
-
15:05 GMT
CLAD after lung transplantation: Pathogenesis, current treatment landscape, and unmet needs
-
15:20 GMT
ECP in the treatment of CLAD: Therapeutic rationale and mechanism of action
-
15:30 GMT
Clinical evidence for ECP in the treatment of CLAD
-
15:45 GMT
Panel discussion: Exploring the role of ECP in CLAD management
-
15:55 GMT
Closing remarks and EBAC evaluation
Learning objectives
Following the symposium, learners will be able to:
- Describe the pathogenesis of CLAD, current treatment approaches, and the unmet clinical needs.
- Describe the biological rationale for the use of CLAD in ECP and the current understanding of its immunomodulatory mechanism of action.
- Appraise the current clinical evidence supporting the use of ECP in the treatment of CLAD.
- Evaluate the potential role of ECP within the future treatment landscape for CLAD.
Registration form
Registration is free.
Thank you!
You have successfully registered for the webinar.
Please check your email for further information on how to attend.
Add to Calendar - download calendar invite file